Replicative senescence and senescence-like state induced in cancer-derived cells

Mechanisms of Ageing and Development

Volumn 123, Issue 12, 2002, Pages 1681-1694

  Hwang, Eun Seong ^a  

^a University of Seoul   (South Korea)

Author keywords

Cancer; Cell cycle inhibition; HeLa; p53; Senescence; Telomerase; Telomere

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; PROTEIN P16; PROTEIN P21; PROTEIN P53; TELOMERASE;

AGING; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA CELL; CELL CYCLE; CELL IMMORTALIZATION; ENZYME INACTIVATION; GENE EXPRESSION; HUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SENESCENCE; TELOMERE; WART VIRUS; CELL AGING; CELL DIVISION; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

CELL AGING; CELL DIVISION; HUMANS; NEOPLASMS; TELOMERE;

EID: 0036860225     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(02)00102-1     Document Type: Article

References (83)

1. Alcorta D.A., Xiong Y., Phelps D., Hannon G., Beach D., Barrett J.C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA. 93:1996;13742-13747.
2. Backsch C., Wagenbach N., Nonn M., Leistritz S., Stanbridge E., Schneider A., Durst M. Microcell-mediated transfer of chromosome 4 into HeLa cells suppresses telomerase activity. Genes Chromosomes Cancer. 31:2001;196-198.
3. Boyer S.N., Wazer D.E., Band V. E7 protein of human papillomavirus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56:1996;4620-4624.
4. Bringold F., Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol. 35:2000;317-329.
5. Brown J.P., Wei W., Sedivy J.M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal dipoid human fibroblasts. Science. 277:1997;831-834.
6. Calbo J., Marotta M., Cascallo M., Roig J.M., Gelpi J.L., Fueyo J., Mazo A. Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer. Cancer Gene Therapy. 8:2001;740-750.
7. Campisi J. From cells to organisms: can we learn about aging from cells in culture. Exp. Gerontol. 36:2001;607-618.
8. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11:2001;S27-S31.
9. Chang B.D., Broude E.V., Dokmanovic M., Zhu H., Ruth A., Xuan Y., Kandel E.S., Lausch E., Christov K., Roninson I.B. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59:1999;3761-3767.
10. Chang B.D., Xuan Y., Broude E.V., Zhu H., Schott B., Fang J., Roninson I.B. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene. 18:1999;4808-4818.
11. Chang B.D., Watanabe K., Broude E.V., Fang J., Poole J.C., Kalinichenko T.V., Roninson I.B. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc. Natl. Acad. Sci. USA. 97:2000;4291-4296.
12. Chang B.D., Swift M.E., Shen M., Fang J., Broude E.V., Roninson I.B. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc. Natl. Acad. Sci. USA. 99:2002;389-394.
13. Chen Q., Fischer A., Reagan J.D., Yan L.J., Ames B.N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl. Acad. Sci. USA. 92:1995;4337-4341.
14. Dai C.Y., Enders G.H. p16 INK4a can initiate an autonomous senescence program. Oncogene. 19:2000;1613-1622.
15. Damm K., Hemmann U., Garin-Chesa P., Hauel N., Kauffmann I., Priepke H., Niestroj C., Daiber C., Enenkel B., Guilliard B., Lauritsch I., Muller E., Pascolo E., Sauter G., Pantic M., Martens U.M., Wenz C., Lingner J., Kraut N., Rettig W.J., Schnapp A. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 20:2001;6958-6968.
16. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9363-9367.
17. Dimri G.P., Testori A., Acosta M., Campisi J. Replicative senescence, aging and growth-regulatory transcription factors. Biol. Signals. 5:1996;154-162.
18. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
19. Fang L., Lee S.W., Aaronson S.A. Comparative analysis of p73 and p53 regulation and effector functions. J. Cell Biol. 147:1999;823-830.
20. Fang L., Igarashi M., Leung J., Sugrue M.M., Lee S.W., Aaronson S.A. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene. 18:1999;2789-2797.
21. Fuxe J., Akusjarvi G., Goike H.M., Roos G., Collins V.P., Pettersson R.F. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A. Cell Growth Differ. 11:2000;373-384.
22. Gewin L., Galloway D.A. E Box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol. 75:2001;7198-7201.
23. Goodwin E.C., DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. USA. 97:2000;12513-12518.
24. Goodwin E.C., DiMaio D. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres. Cell Growth Differ. 12:2001;525-534.
25. Goodwin E.C., Yang E., Lee C.J., Lee H.W., DiMaio D., Hwang E.S. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA. 97:2000;10978-10983.
26. Hahn W.C., Stewart S.A., Brooks M.W., York S.G., Eaton E., Kurachi A., Beijersbergen R.L., Knoll J.H., Meyerson M., Weinberg R.A. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5:1999;1164-1170.
27. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
28. Hayflick L., Moorehead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:1961;585-621.
29. Herbert B., Pitts A.E., Baker S.I., Hamilton S.E., Wright W.E., Shay J.W., Corey D.R. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. USA. 96:1999;14276-14281.
30. Higashi H., Suzuki-Takahashi I., Yoshida E., Nishimura S., Kitagawa M. Expression of p16INK4a suppresses the unbounded and anchorage-independent growth of a glioblastoma cell line that lacks p16INK4a. Biochem. Biophys. Res. Commun. 231:1997;743-750.
31. Hwang E.S., Naeger L.K., DiMaio D. Activation of the endogenous p53 growth inhibitiory pathway in heal cervical carcinoma cells by expression of the bovine papillomavirus E2 gene. Oncogene. 12:1996;795-803.
32. Itahana K., Dimri G., Campisi J. Regulation of cellular senescence by p53. Eur. J. Biochem. 268:2001;2784-2791.
33. Jung M.S., Yun J., Chae H.D., Kim J.M., Kim S.C., Choi T.S., Shin D.Y. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene. 20:2001;5818-5825.
34. Kagawa S., Fujiwara T., Kadowaki Y., Fukazawa T., Sok-Joo R., Roth J.A., Tanaka N. Overexpression of the p21 sdi1 gene induces senescence-like state in human cancer cells: implication for senescence-directed molecular therapy for cancer. Cell Death Differ. 6:1999;765-772.
35. Kallassy M., Martel N., Damour O., Yamasaki H., Nakazawa H. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression. Mol. Carcinog. 21:1998;26-36.
36. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
37. Kiyono I., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., Klingelhutz A.J. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:1998;84-88.
38. Klingelhutz A.J., Foster S.A., McDougall J.K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature. 380:1996;79-82.
39. Kramer D.L., Chang B.D., Chen Y., Diegelman P., Alm K., Black A.R., Roninson I.B., Porter C.W. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Cancer Res. 61:2001;7754-7762.
40. Lee C.J., Suh E.J., Kang H.T., Im O.S., Um S.J., Park J.S., Hwang E.S. Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalised by HPV16 DNA. Exp. Cell Res. 277:2002;173-182.
41. Liu T.J., el-Naggar A.K., McDonnell T.J., Steck K.D., Wang M., Taylor D.L., Clayman G.L. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 55:1995;3117-3122.
42. Lundberg A.S., Hahn W.C., Gupta P., Weinberg R.A. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12:2000;705-709.
43. Macip S., Igarashi M., Fang L., Chen A., Pan Z., Lee S.W., Aaronson S.A. Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J. 21:2002;2180-2188.
44. McConnell B.B., Starborg M., Brookes S., Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 8:1998;351-354.
45. Nakano K., Mizuno T., Sowa Y., Orita T., Yoshino T., Okuyama Y., Fujita T., Ohtani-Fujita N., Matsukawa Y., Tokino T., Yamagishi H., Oka T., Nomura H., Sakai T. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 272:1997;199-206.
46. Noda A., Ning Y., Venable S.F., Pereira-Smith O.M., Smith J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:1994;90-98.
47. Oh S.T., Kyo S., Laimins L.A. Telomerase activation by human papillomavirus type 16E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J. Virol. 75:2001;5559-5566.
48. Park M., Chae H.D., Yun J., Jung M., Kim Y.S., Kim S.H., Han M.H., Shin D.Y. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. Cancer Res. 60:2000;542-545.
49. Pereira-Smith O.M., Smith J.R. Evidence for the recessive nature of cellular immortality. Science. 221:1983;964-966.
50. Poignee M., Backsch C., Beer K., Jansen L., Wagenbach N., Stanbridge E.J., Kirchmayr R., Schneider A., Durst M. Evidence for a putative senescence gene locus within the chromosomal region 10p14-p15. Cancer Res. 61:2001;7118-7121.
51. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
52. Ruth A.C., Roninson I.B. Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation. Cancer Res. 60:2000;2576-2578.
53. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
54. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85:1996;27-37.
55. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602.
56. Shay J.W., Bacchetti S. A survey of teloerase activity in human cancer. Eur. J. Cancer. 33:1997;787-791.
57. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., Von Zglinicki T., Davies K.J. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J. 14:2000;1408-1490.
58. Sitte N., Merker K., Grune T., Von Zglinicki T. Lipofuscin accumulation in proliferating fibroblasts in vitro: an indicator of oxidative stress. Exp. Gerontol. 36:2001;475-486.
59. Smith J.R., Whitney R.G. Intraclonal variation in proliferative potential of human diploid fibroblasts: stochastic mechanism for cellular aging. Science. 207:1980;82-84.
60. Stuart D.T., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., Park S.H., Thompson T., Karsenty G., Bradley A., Donehower L.A. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:2002;45-53.
61. Sugrue M.M., Shin D.Y., Lee S.W., Aaronson S.A. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA. 94:1997;9648-9653.
62. Sun O., Thomson B., Cathers B.E., Salazar M., Kerwin S.M., Trent J.O., Jenkins T.C., Neidle S., Hurley L.H. Inhibition of human telomerase by a G-quadruplex-interactive compound. J. Med. Chem. 40:1997;2113-2116.
63. Suzuki T., Minagawa S., Michishita E., Ogino H., Fujii M., Mitsui Y., Ayusawa D. Induction of senescence-associated genes by 5-bromodeoxyuridine in HeLa cells. Exp. Gerontol. 36:2001;465-474.
64. Tanaka H., Horikawa I., Kugoh H., Shimizu M., Barrett J.C., Oshimura M. Telomerase-independent senescence of human immortal cells induced by microcell-mediated chromosome transfer. Mol. Carcinog. 25:1999;249-255.
65. te Poele R.H., Okorokov A.L., Jardine L., Cummings J., Joel S.P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62:2002;1876-1883.
66. Terao Y., Nishida J., Horiuchi S., Rong F., Ueoka Y., Matsuda T., Kato H., Furugen Y., Yoshida K., Kato K., Wake N. Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells. Int. J. Cancer. 94:2001;257-267.
67. Timmermann S., Hinds P.W., Munger K. Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2′-deoxycytidine treatment induces a senescence-like state. Oncogene. 17:1998;3445-3453.
68. Toussaint O., Medrano E.E., Von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp. Gerontol. 35:2000;927-945.
69. Uejima H., Shinohara T., Nakayama Y., Kugoh H., Oshimura M. Mapping a novel cellular-senescence gene to human chromosome 2q37 by irradiation microcell-mediated chromosome transfer. Mol. Carcinog. 22:1998;34-45.
70. Uhrbom L., Nister M., Westermark B. Induction of senescence in human malignant glioma cells by p16INK4A. Oncogene. 15:1997;505-514.
71. Veldman T., Horikawa I., Barrett J.C., Schlegel R. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J. Virol. 75:2001;4467-4472.
72. Vogt M., Haggblom C., Yeargin J., Christiansen-Weber T., Haas M. Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ. 9:1998;139-146.
73. Von Zglinicki T., Nilsson E., Docke W.D., Brunk U.T. Lipofuscin accumulation and ageing of fibroblasts. Gerontology. 41:(Suppl. 2):1995;95-108.
74. Wainwright L.J., Lasorella A., Iavarone A. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc. Natl. Acad. Sci. USA. 98:2001;9396-9400.
75. Wei S., Wei S., Sedivy J.M. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 59:1999;1539-1543.
76. Wells S.I., Francis D.A., Karpova A.Y., Dowhanick J.J., Benson J.D., Howley P.M. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J. 19:2000;5762-5771.
77. Xu H.J., Zhou Y., Ji W., Perng G.S., Kruzelock R., Kong C.T., Bast R.C., Mills G.B., Li J., Hu S.X. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene. 15:1997;2589-2596.
78. Xu D., Wang Q., Gruber A., Bjorkholm M., Chen Z., Zaid A., Selivanova G., Peterson C., Wiman K.G., Pisa P. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene. 19:2000;5123-5133.
79. Yun J., Chae H.D., Choy H.E., Chung J., Yoo H.S., Han M.H., Shin D.Y. p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J. Biol. Chem. 274:1999;29677-29682.
80. Zhang X., Mar V., Zhou W., Harrington L., Robinson M.O. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 13:1999;2388-2399.
81. Zhen X., Lu K.P. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell. 107:2001;347-359.
82. Zindy F., Quelle D.E., Roussel M.F., Sherr C.J. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene. 15:1997;203-211.
83. Zhu J., Woods D., McMahon M., Bishop J.M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:1998;2997-3007.